교육시간 |
ROOM 1 [1F |
08:50~09:15 |
Anti-Hepatitis B Virus Therapy in Special Population |
Jeong-Hoon Lee |
Seoul National Univ. |
교육시간 |
ROOM 1 [1F |
09:15~09:40 |
Anti-Hepatitis C Virus Therapy in Real-World Practice |
Geum-Youn Gwak |
Sungkyunkwan Univ. |
교육시간 |
ROOM 1 [1F |
09:40~10:05 |
Hepatitis E Virus: Epidemiology, Diagnosis, and Management |
Nae-Yun Heo |
Inje Univ. |
교육시간 |
ROOM 1 [1F |
10:05~10:30 |
Future Hepatitis B Virus Therapy |
Jung Hyun Kwon |
The Catholic Univ. of Korea |
교육시간 |
ROOM 1 [1F |
10:50~11:15 |
Coverts and Overt Hepatic Encephalopathy |
Sang Gyune Kim |
Soonchunhyang Univ. |
교육시간 |
ROOM 1 [1F |
11:15~11:40 |
Frailty and Sarcopenia in Cirrhosis |
Seung Up Kim |
Yonsei Univ. |
교육시간 |
ROOM 1 [1F |
11:40~12:05 |
Interventional Treatment of Varices: TIPS, BRTO, and PARTO |
Dongho Hyun |
Sungkyunkwan Univ. |
교육시간 |
ROOM 1 [1F |
12:05~12:30 |
Sepsis in Cirrhosis: New Definition and Application |
Dae Hee Choi |
Kangwon National Univ. |
교육시간 |
ROOM 1 [1F |
13:50~14:15 |
Alcoholic Hepatitis from 1971 to 2019 |
Soung Won Jeong |
Soonchunhyang Univ. |
교육시간 |
ROOM 1 [1F |
14:15~14:40 |
Update on Imaging and Serum Biomarkers of Non-Alcoholic Fatty Liver Disease |
Won Kim |
Seoul National Univ. |
교육시간 |
ROOM 1 [1F |
14:40~15:05 |
Real Treatment Target of Non-Alcoholic Fatty Liver Disease: Steatosis vs. Fibrosis? |
Dae Won Jun |
Hanyang Univ. |
교육시간 |
ROOM 1 [1F |
15:05~15:30 |
Metabolic Syndrome in Non-Alcoholic Fatty Liver Disease from Hepatologist's Perspective |
Yang Hyon Baek |
Dong-A Univ. |
교육시간 |
ROOM 1 [1F |
15:50~16:15 |
Radiologic Assessment of Hepatic Nodules |
Jin-Young Choi |
Yonsei Univ. |
교육시간 |
ROOM 1 [1F |
16:15~16:40 |
Surveillance of Hepatocellular Carcinoma: Risk Stratification |
Sung Bum Cho |
Chonnam National Univ. |
교육시간 |
ROOM 1 [1F |
16:40~17:05 |
Clinical Decision of Surgical Management: Benign Lesions |
Sae Byeol Choi |
Korea Univ. |
교육시간 |
ROOM 1 [1F |
17:05~17:30 |
Clinical Decision of Surgical Management: Hepatocellular Carcinoma and Cholangiocarcinoma |
Gi-Won Song |
Univ. of Ulsan |
교육시간 |
ROOM D [2F |
10:50~11:15 |
Molecular Basis for Cure of Hepatitis B Virus Infection |
Kyun-Hwan Kim |
Konkuk Univ. |
교육시간 |
ROOM D [2F |
11:15~11:40 |
Targeting of Hepatitis B Virus Capsid Assembly for Anti-Hepatitis B Virus Drug Development |
Sung Gyoo Park |
GIST |
교육시간 |
ROOM D [2F |
11:40~12:05 |
Identification and Validation of Druggable Targets in the Hepatitis C Virus Life Cycle |
Soon Bong Hwang |
Chonbuk National Univ. |
교육시간 |
ROOM D [2F |
12:05~12:30 |
Hepatitis C Virus Vaccine Development |
Eui-Cheol Shin |
KAIST |
교육시간 |
ROOM D [2F |
13:50~14:15 |
Understanding of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma |
Su-Hyung Park |
KAIST |
교육시간 |
ROOM D [2F |
14:15~14:40 |
Hepatocarcinogenesis and Animal Model |
Weonsang Ro |
Yonsei Univ. |
교육시간 |
ROOM D [2F |
14:40~15:05 |
Endocannabinoid and Alcoholic Fatty Liver |
Won-il Jeong |
KAIST |
교육시간 |
ROOM D [2F |
15:05~15:30 |
Pathogenesis of Non-Alcoholic Steatohepatitis |
Sang Geon Kim |
Seoul National Univ. |
교육시간 |
ROOM D [2F |
15:50~16:00 |
강원지회 |
Minjong Lee |
Gangwon National Univ. |
교육시간 |
ROOM D [2F |
16:00~16:10 |
경기-인천지회 |
Jeong-Ju Yoo |
Soonchunhyang Univ. |
교육시간 |
ROOM D [2F |
16:10~16:20 |
광주-전남지회 |
Chung Hwan Jun |
Chonnam National Univ. |
교육시간 |
ROOM D [2F |
16:20~16:30 |
대구-경북지회 |
Jung Gil Park |
Yeungnam Univ. |
교육시간 |
ROOM D [2F |
16:30~16:40 |
대전-충청지회 |
Suk Bae Kim |
Dankook Univ. |
교육시간 |
ROOM D [2F |
16:40~16:50 |
부산-울산-경남지회 |
Nae-Yun Heo |
Inje Univ. |
교육시간 |
ROOM D [2F |
16:50~17:00 |
전북지회 |
Chang Hun Lee |
Chonbuk National Univ. |
교육시간 |
ROOM D [2F |
17:00~17:10 |
제주지회 |
Young Nam Kim |
Cheju Halla General Hospital |
교육시간 |
ROOM D [2F |
17:10~17:30 |
Discussion |
|
|
교육시간 |
ROOM A [1F |
08:30~08:50 |
Fecal Microbiota Transplant in Alcohol-Related Liver Diseases |
SM Shasthry |
Institute of Liver and Biliary Sciences, India |
교육시간 |
ROOM A [1F |
08:50~09:10 |
Systemic Manifestation in Non-Alcoholic Fatty Liver Disease |
Donghee Kim |
Stanford Univ., USA |
교육시간 |
ROOM A [1F |
09:10~09:30 |
Update on the Management of Non-Alcoholic Fatty Liver Disease |
Vincent Wong |
The Chinese Univ. of Hong Kong, Hong Kong |
교육시간 |
ROOM A [1F |
11:10~11:25 |
Nucleoside Analogue NUC) Treatment Can Be Discontinued |
Chun-Jen Liu |
National Taiwan Univ., Taiwan |
교육시간 |
ROOM A [1F |
11:25~11:40 |
NUC Treatment Should Be Continued |
Young-Suk Lim |
Univ. of Ulsan |
교육시간 |
ROOM A [1F |
11:40~12:10 |
Panel Discussion |
Hyung Joon Yim, Wai-Kay Seto |
Korea Univ. , Univ. of Hong Kong, Hong Kong |
교육시간 |
ROOM A [1F |
13:30~14:00 |
Hepatitis B Virus: From Control to Cure |
Jia-Horng Kao |
Taiwan National Univ., Taiwan |
교육시간 |
ROOM A [1F |
14:00~14:20 |
Viral factors for Hepatitis B Virus-Related Hepatocellular Carcinoma |
Jeong Won Jang |
The Catholic Univ. of Korea |
교육시간 |
ROOM A [1F |
14:20~14:40 |
Novel Biomarkers in Management of Chronic Hepatitis B |
Yasuhito Tanaka |
Nagoya City Univ., Japan |
교육시간 |
ROOM A [1F |
14:40~15:00 |
Current Treatment Strategy: Toward Hepatitis B Virus Cure |
Seng Gee Lim |
National Univ. of Singapore, Singapore |
교육시간 |
ROOM A [1F |
15:00~15:20 |
Future Treatment Strategy: Toward Hepatitis B Virus Cure |
Henry LY Chan |
The Chinese Univ. of Hong Kong, Hong Kong |
토론 |
ROOM A [1F |
15:20~15:30 |
Discussion |
|
|
교육시간 |
ROOM A [1F |
16:30~16:50 |
Chronic Hepatitis B: Where Are We Now for Functional Cure? |
Hyun Woong Lee |
Yonsei Univ. |
교육시간 |
ROOM A [1F |
16:50~17:10 |
Non-Alcoholic Steatohepatitis: Key Targets and Endpoints |
Byoung Kuk Jang |
Keimyung Univ. |
교육시간 |
ROOM A [1F |
17:10~17:30 |
Cirrhosis: Effort against Fibrosis and Portal Hypertension |
Kyung-Ah Kim |
Inje Univ. |
교육시간 |
ROOM A [1F |
17:30~17:50 |
Hepatocellular Carcinoma Treatment Showdown: Mono vs. Combination Therapy |
Ju Hyun Shim |
Univ. of Ulsan |
교육시간 |
ROOM B [1F |
07:30~07:55 |
Management of Cirrhotic Complications: Guidelines and Real Experience |
C. Rinaldi A. Lesmana |
Univ. of Indonesia, Indonesia |
교육시간 |
ROOM B [1F |
07:55~08:20 |
Key Summary of EASL Clinical Practice Guidelines for the Management of Patients with Decompensated Cirrhosis |
Paolo Angeli |
Univ. of Padova, Italy |
토론 |
ROOM B [1F |
08:20~08:30 |
Discussion |
|
|
교육시간 |
ROOM C [1F |
07:30~07:50 |
Recent Epidemiology of Non-Alcoholic Fatty Liver Disease |
Donghee Kim |
Stanford Univ., USA |
교육시간 |
ROOM C [1F |
07:50~08:10 |
Non-Alcoholic Fatty Liver Disease and Diabetes: Chicken or Egg? |
Eun-Jung Rhee |
Sungkyunkwan Univ. |
토론 |
ROOM C [1F |
08:10~08:30 |
Discussion |
|
|
교육시간 |
ROOM BC [1 |
11:10~11:25 |
Treatment of Chronic Hepatitis B and C |
Eileen L. Yoon |
Inje Univ. |
교육시간 |
ROOM BC [1 |
11:25~11:40 |
Management of Acute Variceal Bleeding |
Seung Kak Shin |
Gachon Univ. |
교육시간 |
ROOM BC [1 |
11:40~11:55 |
Liver Transplantation: When and How? |
Bum Soo Kim |
Kyung Hee Univ. |
교육시간 |
ROOM BC [1 |
11:55~12:10 |
Hepatocellular Carcinoma: Diagnosis and Tumor Staging |
Woo Jin Chung |
Keimyung Univ. |
교육시간 |
ROOM D [1F |
11:10~11:25 |
Exceptional Insurances in the Field of End-Stage Liver Disease |
Jeong Han Kim |
Konkuk Univ. |
교육시간 |
ROOM D [1F |
11:25~11:40 |
Policy of KASL for Elimination of Hepatitis |
Sung Eun Kim |
Hallym Univ. |
교육시간 |
ROOM D [1F |
11:40~11:55 |
Liver Disease-Related Issue to Strengthen Health Insurance Coverage Expansion Policy |
Eun Sun Jang |
Seoul National Univ. |
교육시간 |
ROOM D [1F |
11:55~12:10 |
Future Policy of Government for Administration of Chronic Liver Disease |
Young Ki Jeong |
Ministry of Health and Welfare |
교육시간 |
ROOM D [1F |
14:00~14:20 |
Overview of Hepatitis Prevention and Control in the Republic of Korea |
Sung Won Lee |
The Catholic Univ. of Korea |
교육시간 |
ROOM D [1F |
14:20~14:40 |
National Viral Hepatitis Control Plan |
Don Han Lee |
Korea Centers for Disease Control and Prevention |
교육시간 |
ROOM D [1F |
14:40~14:55 |
Korea HBV Cohort Study |
Beom Kyung Kim |
Yonsei Univ. |
교육시간 |
ROOM D [1F |
14:55~15:10 |
Korea HCV Cohort Study |
Eun Sun Jang |
Seoul National Univ. |
토론 |
|
15:10~15:30 |
Discussion |
|
|
교육시간 |
ROOM E [1F |
14:00~14:20 |
Comparison of Bone Marrow-derived Mesenchymal Stem Cells Isolated from Normal and Cirrhotic Patients |
Young Woo Eom |
Yonsei Univ. Wonju |
교육시간 |
ROOM E [1F |
14:20~14:40 |
Feasibility of Enhanced PRL-1 in Placenta-derived Mesenchymal Stem Cells by Gene Modification on a Rat Model with Hepatic Failure |
Gi Jin Kim |
CHA Univ. |
교육시간 |
ROOM E [1F |
14:40~15:00 |
Vascularized Liver Tissue with Different Types of Endothelial Cells and Recovery Aids for Acute Liver Failure |
Soo Hyun Kim |
KIST |
교육시간 |
ROOM E [1F |
15:00~15:20 |
MicroRNA Profile Analysis in Liver Fibrotic Tissue and Hepatic Differentiated Human Bone Marrow-derived Mesenchymal Stem Cells |
Jung Hoon Cha |
The Catholic Univ. of Korea |
교육시간 |
ROOM E [1F |
15:20~15:40 |
Proteomics Approach for Translational Research, Focusing on Liver Disease |
Kyung Kon Kim |
Univ. of Ulsan |
교육시간 |
ROOM A [2F |
08:30~09:00 |
Updated Liver Allograft Pathology |
Chris Bellamy |
The Univ. of Edinburgh, Scotland |
교육시간 |
ROOM A [2F |
09:00~09:30 |
Is it Need Protocol Biopsy in Liver Recipient? |
Suk Kyun Hong |
Seoul National Univ. |
교육시간 |
ROOM A [2F |
11:10~11:25 |
Pathological Point of View of Combined HCC and CCC: What Is the Origin and Diagnostic Criteria of Combined HCC and CCC |
Young Nyun Park |
Yonsei Univ. |
교육시간 |
ROOM A [2F |
11:25~11:40 |
Imaging Features of Combined HCC and CCC: What Is the Difference Compared with HCC or CCC? |
Chang-Hee Lee |
Korea Univ. |
교육시간 |
ROOM A [2F |
11:40~11:55 |
Surgical Treatment and Prognosis of Combined HCC and CCC |
Matsuyama Ryusei |
Yokohama City Univ., Japan |
교육시간 |
ROOM A [2F |
11:55~12:10 |
Issues of Combined HCC and CCC in Liver Transplantation |
Young Seok Han |
Kyungpook National Univ. |
교육시간 |
ROOM A [2F |
13:30~14:00 |
Donation after Circulatory Death Liver Procurement in Real Practice |
Koji Hashimoto |
Cleveland Clinic, USA |
교육시간 |
ROOM A [2F |
14:10~14:30 |
Current Status and Problems of Organ Donation |
Won Hyun Cho |
Korea Organ Donation Agency |
교육시간 |
ROOM A [2F |
14:30~14:50 |
Current Status of Liver Allocation System |
Jae Geun Lee |
Yonsei Univ. |
교육시간 |
ROOM A [2F |
14:50~15:10 |
Institutional Issue and Limit of Donation after Cardiac Death |
Dong-Sik Kim |
Korea Univ. |
토론 |
ROOM A [2F |
15:10~15:30 |
Panel Discussion |
Jeong-Rim Lee |
Korea Organ Donation Agency, TBD |
교육시간 |
ROOM A [2F |
16:30~16:50 |
HRS: Definition, Pathophysiology and Medical Management |
Yeon Seok Seo |
Korea Univ. |
교육시간 |
ROOM A [2F |
16:50~17:10 |
When to Consider SLK and How to Prevent Adverse Renal Outcome after Liver Transplantation |
Jae Min Chun |
Kyungpook National Univ. |
교육시간 |
ROOM A [2F |
17:10~17:30 |
MELD Purgatory in HRS and Allocation Policy: When to Start Renal Replacement Therapy? |
Shin Hwang |
Univ. of Ulsan |
교육시간 |
ROOM A [2F |
17:30~17:50 |
Optimal Time to Start Renal Replacement Therapy: Nephrologist' Viewpoint |
Hye Ryoun Jang |
Sungkyunkwan Univ. |
교육시간 |
ROOM B [2F |
14:10~14:30 |
Recovery Management for Old Age Recipient |
Man Ki Ju |
Yonsei Univ. |
교육시간 |
ROOM B [2F |
14:30~14:50 |
Transplantation Counseling for old Age Recipient |
Hyung Sook Kim |
Seoul St. Mary's Hospital |
교육시간 |
ROOM B [2F |
14:50~15:10 |
Acute Liver Failure |
Dong Jin Joo |
Yonsei Univ. |
교육시간 |
ROOM B [2F |
15:10~15:30 |
Patient Management after Liver Transplantation |
Seung Heui Hong |
Samsung Medical Center |
교육시간 |
ROOM D [2F |
08:30~08:50 |
Surveillances for HCC in Patients with NAFLD |
Vincent Wong |
The Chinese Univ. of Hong Kong, Hong Kong |
교육시간 |
ROOM D [2F |
08:50~09:10 |
Are Emerging Biomarkers and Imaging Tools Better than Routine Abdominal Sonography for HCC Surveillance? |
Do Young Kim |
Yonsei Univ. |
교육시간 |
ROOM D [2F |
09:10~09:30 |
Is LI-RADS Better for Diagnosis of HCC |
Jeong Min Lee |
Seoul National Univ. |
교육시간 |
ROOM D [2F |
11:10~11:25 |
0202 Liver Day Special Lecture |
Hyun Woong Lee |
Yonsei Univ. |
교육시간 |
ROOM D [2F |
13:30~13:50 |
Circulating Tumor Cells and Cell-Free Nucleic Acids |
Takahiiro Ochiai |
Tokyo Medical Univ., Japan |
교육시간 |
ROOM D [2F |
13:50~14:10 |
CAR-Associated Adoptive Immunotherapy |
Yutaka Kawakami |
Keio Univ., Japan |
교육시간 |
ROOM D [2F |
14:10~14:30 |
Oncolytic Virus-Based Therapy for HCC |
Jeong Heo |
Pusan National Univ. |
교육시간 |
ROOM D [2F |
14:30~14:45 |
Recent Trends of Treatment for Intermediate Stage HCC: Japanese Experience |
Masatoshi Kudo |
Kindai Univ., Japan |
교육시간 |
ROOM D [2F |
14:45~15:00 |
Recent Trends of Treatment for Intermediate Stage HCC: Korean Experience |
Ji Hoon Kim |
Korea Univ. |
교육시간 |
ROOM D [2F |
15:00~15:15 |
Recent Trends of Treatment for Advanced Stage HCC: Japanese Experience |
Kazuomi Ueshima |
Kindai Univ., Japan |
교육시간 |
ROOM D [2F |
15:15~15:30 |
Recent Trends of Treatment for Advanced Stage HCC: Korean Experience |
Won Young Tak |
Kyungpook National Univ. |
교육시간 |
ROOM D [2F |
16:30~16:50 |
First Line Treatments for HCC |
Arndt Vogel |
Hannover Medical School, Germany |
교육시간 |
ROOM D [2F |
16:50~17:10 |
Second Line Treatments for HCC |
Anthony El-Khoueiry |
Univ. of Southern California Norris Comprehensive Cancer Center, USA |
교육시간 |
ROOM D [2F |
17:10~17:30 |
A Future of Systemic Agents: Emerging Therapies and Strategies |
Baek-Yeol Ryoo |
Univ. of Ulsan |
교육시간 |
ROOM D [2F |
17:30~17:50 |
Combination of Interventional and Systemic Therapies: Current Status and Future Direction |
Joong-Won Park |
National Cancer Center Korea |
교육시간 |
ROOM A [1F |
09:00~09:20 |
Long-Term Outcome of Direct-Acting Antiviral Treatment |
Jung Il Lee |
Yonsei Univ. |
교육시간 |
ROOM A [1F |
09:20~09:40 |
Follow-Up Strategies Following Cure of Hepatitis C Virus Infection |
Naoya Sakamoto |
Hokkaido Univ., Japan |
교육시간 |
ROOM A [1F |
09:40~10:00 |
Unmet Needs in the Era of Direct-Acting Antiviral Therapy |
Ming-Lung Yu |
Kaohsiung Medical Univ., Taiwan |
교육시간 |
ROOM A [1F |
10:20~10:50 |
Hepatic Encephalopathy and Variceal Bleeding |
Jae Young Jang |
Soonchunhyang Univ. |
교육시간 |
ROOM A [1F |
10:50~11:20 |
Current Understanding of Autoimmune Liver Diseases |
Atsushi Tanaka |
Teikyo Univ., Japan |
교육시간 |
ROOM A [1F |
14:30~14:50 |
Regenerative Therapy for Liver Cirrhosis: From Auto to Allo |
Shuji Terai |
Niigata Univ., Japan |
교육시간 |
ROOM A [1F |
14:50~15:10 |
The Role of Albumin Related with Systemic Inflammation in Cirrhosis |
Paolo Angeli |
Univ. of Padova, Italy |
교육시간 |
ROOM A [1F |
15:10~15:30 |
Role of Cytoglobin, a Novel Radical Scavenger in Stellate Cell Activation and Hepatic Fibrosis |
Norifumi Kawada |
Osaka City Univ., Japan |
토론 |
ROOM A [1F |
15:30~15:40 |
Discussion |
|
|
교육시간 |
ROOM A [1F |
15:40~15:55 |
Best Presentations of KASL |
Jun Yong Park |
Yonsei Univ. |
교육시간 |
ROOM A [1F |
15:55~16:10 |
Best Presentations of KAHBPS |
Sae Byeol Choi |
Korea Univ. |
교육시간 |
ROOM A [1F |
16:10~16:25 |
Best Presentations of KLCA |
Su Jong Yu |
Seoul National Univ. |
교육시간 |
ROOM A [1F |
16:25~16:40 |
Best Presentations of KLTS |
Jae Geun Lee |
Yonsei Univ. |
교육시간 |
ROOM B+C [ |
09:00~09:20 |
Surgeon-Scientists: An Endangered Species? |
Sundeep G. Keswani |
Baylor College of Medicine, USA |
교육시간 |
ROOM B+C [ |
09:20~09:40 |
Basic/Translational Research (How to start and grow?) |
Say-June Kim |
The Catholic Univ. of Korea |
교육시간 |
ROOM B+C [ |
09:40~10:00 |
Clinical/Multi-Institutional Research |
Manabu Kawai |
Wakayama Medical Univ., Japan |
교육시간 |
ROOM B+C [ |
10:20~10:35 |
1-1) Medical Treatment: Indication and Result of Medical Treatment |
Ki Tae Suk |
Hallym Univ. |
교육시간 |
ROOM B+C [ |
10:35~10:50 |
1-2) Surgical Treatment: What Should We Caution to Consider Surgery? |
Shang Yu Wang |
Chang-Gung Univ., Taiwan |
교육시간 |
ROOM B+C [ |
10:50~11:05 |
Clinical Outcomes and Prognosis of Emergency Surgery in Liver Cirrhosis Patient |
Fausto Catena |
Univ. of Bologna, Italy |
교육시간 |
ROOM B+C [ |
11:05~11:20 |
Elective Cancer Surgery in Patients with Liver Cirrhosis |
Sae Byeol Choi |
Korea Univ. |
교육시간 |
ROOM B+C [ |
14:30~14:50 |
The Operative Indication of Advanced Gallbladder Cancer: How Much Advance Is the Limitation? |
Masayuki Ohtsuka |
Chiba Univ., Japan |
교육시간 |
ROOM B+C [ |
14:50~15:10 |
Recent Advances in the Chemotherapy in Advanced Gallbladder Cancer: Palliative vs. Neoadjuvant Chemotherapy |
Hei-Cheul Jeung |
Yonsei Univ. |
토론 |
ROOM B+C [ |
15:10~15:30 |
Case Discussion |
Chi-Young Jeong |
Gyeongsang National Univ. |
교육시간 |
ROOM D [1F |
10:20~10:35 |
National Health Insurance Big Data Anaysis: Process and Example |
Seong Yong Park |
National Health Insurance Service |
교육시간 |
ROOM D [1F |
10:35~10:50 |
National Health Insurance Big Data Research I : HCC Surveillance |
Yong-Han Paik |
Sungkyunkwan Univ. |
교육시간 |
ROOM D [1F |
10:50~11:05 |
National Health Insurance Big Data Research II : Nonalcoholic Fatty Liver Disease |
Jung Il Lee |
Yonsei Univ. |
교육시간 |
ROOM D [1F |
11:05~11:20 |
National Health Insurance Big Data Research III : Liver Cirrhosis |
Dae Won Jun |
Hanyang Univ. |
교육시간 |
ROOM A [2F |
14:30~14:45 |
Assessment of Surgical Risk in Patients with Cirrhosis |
Ki Tae Yoon |
Pusan National Univ. |
교육시간 |
ROOM A [2F |
14:45~15:00 |
Determination of Preoperative?Liver Function and Extent of Resection |
Bong-Wan Kim |
Ajou Univ. |
교육시간 |
ROOM A [2F |
15:00~15:15 |
Prophylaxis of Hepatitis B Virus Reactivation after Liver Transplantation |
Jae Hyun Han |
The Catholic Univ. of Korea |
교육시간 |
ROOM A [2F |
15:15~15:30 |
Optimal Hepatitis C Virus Treatment Strategy for Patients Waiting for Liver Transplantation |
In Hee Kim |
Chonbuk National Univ. |
토론 |
ROOM A [2F |
15:30~15:40 |
Discussion |
|
|
교육시간 |
ROOM D [2 |
09:00~09:20 |
Adjuvant Therapy after Curative Treatment: Enough or Still Lacking? |
Su Jong Yu |
Seoul National Univ. |
교육시간 |
ROOM D [2 |
09:20~09:40 |
Direct Acting Antiviral and HCC in Chronic Hepatitis C: Friend or Foe? |
Hyung Joon Kim |
Chung-Ang Univ. |
교육시간 |
ROOM D [2 |
09:40~10:00 |
How to Overcome Long-term Decline in Survival of HCC Patients Treated with Ablation |
Shuichiro Shiina |
Juntendo Univ., Japan |
교육시간 |
ROOM D [2 |
10:20~10:40 |
Will Laparoscopic Approach Be Almighty Weapon in Surgery of HCC |
Jong Man Kim |
Sungkyunkwan Univ. |
교육시간 |
ROOM D [2 |
10:40~11:00 |
Priority Policy for Patients with HCC Awaiting Liver Transplantation: Unresolved Issue? |
Dorry L Segev |
Johns Hopkins Univ., USA |
교육시간 |
ROOM D [2 |
11:00~11:20 |
Radiation Therapy for Early HCC: Will It Be a Good Option in Practice |
Sang Min Yoon |
Univ. of Ulsan |
교육시간 |
ROOM D [2 |
14:20~14:35 |
Current Status and Emerging Issues in Liver Diseases in Japan |
Hayato Hikita |
Osaka Univ., Japan |
교육시간 |
ROOM D [2 |
14:35~14:50 |
Current Status and Emerging Issues in Liver Diseases Taiwan |
Chun-Jen Liu |
National Taiwan Univ. Taiwan |
교육시간 |
ROOM D [2 |
14:50~15:05 |
Current Status and Emerging Issues in Liver Diseases in Korea |
Yoon Jun Kim |
Seoul National Univ. |
교육시간 |
ROOM D [2 |
15:05~15:25 |
Minilecture - Legacy of Portal Hypertension |
Han-Chieh Lin |
National Yang-Ming Univ., Taiwan |
토론 |
ROOM D [2 |
15:25~15:40 |
Discussion |
|
|